Jules Haimovitz
CIK 1340855 · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.42M
Companies
6
Total Filings
36
Lifetime Open-Market Net
$148.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INVA | Director | 152,692 | $21.81 | $3.33M | $0 | 10 | 2026-05-06 |
| ARMP | Director | — | $4.73 | — | $0 | 6 | 2026-03-11 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Director | 0 | — | — | $0 | 3 | 2017-02-16 |
| BCOR | Director | 18,000 | $21.41 | $385.4K | $0 | 1 | 2013-05-23 |
| INSP | Director | 13,500 | $51.97 | $701.6K | $0 | 6 | 2012-06-01 |
| BLOCKBUSTER INC (BBI.B) Delisted | Director | 586,102 | — | — | $148.5K | 9 | 2010-07-06 |
Recent Filings · Page 2 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-20 | INVA | Grant (A) | +17,482 | $0 | EDGAR |
| 2021-04-05 | ARMP | Grant (A) | — | $0 | EDGAR |
| 2020-04-28 | INVA | Grant (A) | +16,917 | $0 | EDGAR |
| 2019-05-24 | INVA | Grant (A) | +16,399 | $0 | EDGAR |
| 2018-04-26 | INVA | Grant (A) | +14,249 | $0 | EDGAR |
| 2018-02-14 | INVA | Grant (A) | +10,517 | $0 | EDGAR |
| 2017-02-16 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Disp (D) | −18,008 | $0 | EDGAR |
| 2017-02-01 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | +18,008 | $0 | EDGAR |
| 2016-05-06 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-23 | BCOR | Grant (A) | +4,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.